The Journal of Cardiovascular Computed Tomography: 2020 Year in review.

The purpose of this review is to highlight the most impactful, educational, and frequently downloaded articles published in the Journal of Cardiovascular Computed Tomography (JCCT) for the year 2020. The JCCT reached new records in 2020 for the number of research submissions, published manuscripts, article downloads and social media impressions. The articles in this review were selected by the Editorial Board of the JCCT and are comprised predominately of original research publications in the following categories: Coronavirus disease 2019 (COVID-19), coronary artery disease, coronary physiology, structural heart disease, and technical advances. The Editorial Board would like to thank each of the authors, peer-reviewers and the readers of JCCT for making 2020 one of the most successful years in its history, despite the challenging circumstances of the global COVID-19 pandemic.

Informations de copyright

Copyright © 2021 Society of Cardiovascular Computed Tomography. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. Subhi Al’Aref is supported by NIH 2R01 HL12766105 and receives royalty fees from Elsevier. Dr. Armin Arbab-Zadeh received grant support from Canon. Dr. Andrew Choi holds equity in Cleerly, Inc. and receives grant support from the GW Heart and Vascular Institute. Dr. Carlo De Cecco received research support from Siemens. Dr. Damini Dey is supported by grants 1R01HL148787-01A1 and 1R01HL151266-01 and received software royalties from Cedars-Sinai Medical Center. Dr. Maros Ferencik received grant support from the National Institutes of Health and the American Heart Association. He is a consultant for Biograph, Inc. Dr. Harvey Hecht is on the scientific advisory board of Arineta and Cleerly, Inc. Dr. Jonathon Leipsic is a consultant and holds stock options in HeartFlow and Circle CVI. He is on the speakers bureau for GE Healthcare and Philips. Institutional grants from GE Healthcare, Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, MVRX, and PI Cardia. Dr. Michael T. Lu MTL is supported by the American Heart Association (810966). Dr. Mohamed Marwan received speaker honoraria and is a consultant for Edwards Lifesciences. Dr. Pál Maurovich-Horvat holds stock in Neumann Medical, Ltd. Dr. Jonathan Weir-McCall is supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The National Heart, Lung and Blood Institute of the National Institutes of Health has an institutional research agreement with Canon Medical Systems. The other authors declared no relevant competing interests.